Contact NY Metropolitan Chapter of ACRP for event and ticket information.

This event has ended!

View current events hosted by NY Metropolitan Chapter of ACRP

Comparing and Contrasting Safety Reporting in Drug and Device Trials

Wednesday, November 4, 2009 from 6:00 PM to 8:30 PM (ET)

New York, NY

Comparing and Contrasting Safety Reporting in Drug and Devic...

Ticket Information

Ticket Type Sales End Price Fee Quantity
NY Metropolitan Chapter Member   more info Ended $0.00 $0.00
Non-member Ended $25.00 $0.00
Share this!

Event Details

Comparing and Contrasting Safety Reporting in Drug and Device Trials

 Speaker:  Lee Truax-Bellows, MS, FNP, CCRA, RQAP-GCP.  President, CEO of NCRA

 

Ms. Truax-Bellows is a certified monitor and registered good clinical practice auditor with extensive experience of regulated research within the pharmaceutical and medical  devices.

 

November 4th, 2009

Lenox Hill Hospital

130 W. 77th (between Park and Lex)

William Black Hall, 2nd Floor, Theater Room

 

Brief Program Description                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

 This program is designed to assist the research professional in identifying and managing safety reporting FDA requirements for both medical device and drug clinical studies.  It will assist the participant in identifying the differences and similarities for safety reporting between the two different types of studies. 

 

 Program Objectives:

1.      The participant should be able to interpret the various definitions and reporting requirements for drug and device studies

2.      The participant should be able to distinguish differences between drug and device reporting requirements and best practices

3.      The participant should be able to explain current regulatory agency activities that impact safety reporting today

 

 Program Agenda: Registration and Networking 6:00-6:40pm;

                            Chapter elections and meeting 6:40-7pm;

                            Educational Program & Q&A 7:00 – 8:30pm

                       

Target Audience: All research professionals